This pilot study has provided some clinical epidemiological clues for the utilization of the ENO1-P6 epitope to develop a clinical prediction biomarker of AIT-related miscarriage and establish the specific therapeutic strategy of immune tolerance. This evidence concerns the gene ENO1 and spontaneous abortion.